United Therapeutics | UTHR - Stock

Aktienkurs
530.88
Täglich Wechseln
-9.14 -1.69%
Monatlich
10.48%
Jährlich
66.50%
Q1 Prognose
519.93




Stock Veränderung Datum
Amarin USD 184.7M 13.46M 2025-09
Ardelyx USD 129.36M 107.08M 2025-09
Baxter International USD 2.23B 228M 2025-12
Bayer EUR 12.33B 221M 2025-09
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Insmed USD 132.07M 11.1M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
J&J USD 14.19B 45M 2025-12
Lexicon Pharmaceuticals USD 168K 33K 2025-06
Moderna USD 332M 92M 2025-09
Omeros USD 712K 266K 2021-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12